Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 15/20 | 0.44 |
| ▸ | RAB9A | P51151 | 12/20 | 0.44 |
| ▸ | HTT | P42858 | 11/20 | 0.44 |
| ▸ | NPC1 | O15118 | 10/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 10/20 | 0.44 |
| ▸ | LMNA | P02545 | 9/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 4/20 | 0.44 |
| ▸ | S1PR2 | O95136 | 3/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 9/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4256051 | 0.82 | ALDH1A1 (0.44) | ALDH1A1RAB9AHTTNPC1NPSR1 | |
| SCHEMBL4253339 | 0.81 | NR2E3 (0.48) | ALDH1A1RAB9AHTTNPC1NPSR1 | |
| SCHEMBL29191615 | 0.81 | NPBWR1 (0.54) | ALDH1A1HTTPKMSMN1; SMN2NPBWR1 | |
| SCHEMBL4254540 | 0.80 | ALDH1A1 (0.37) | ALDH1A1RAB9AHTTNPC1NPSR1 | |
| SCHEMBL1372817 | 0.73 | HTT (0.56) | ALDH1A1RAB9AHTTNPC1NPSR1 | |
| SCHEMBL4255564 | 0.72 | ALDH1A1 (0.44) | ALDH1A1RAB9AHTTNPC1NPSR1 | |
| SCHEMBL25968386 | 0.72 | HPGD (0.34) | ALDH1A1RAB9AHTTNPC1NPSR1 | |
| SCHEMBL4256005 | 0.71 | LMNA (0.38) | ALDH1A1RAB9AHTTNPC1NPSR1 | |
| SCHEMBL1375635 | 0.70 | ALDH1A1 (0.50) | ALDH1A1RAB9AHTTNPC1NPSR1 | |
| SCHEMBL27848654 | 0.68 | RAB9A (0.41) | ALDH1A1RAB9AHTTNPC1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481537-B2 | Caspase inhibitors based of pyridazinone scaffold | LG LIFE SCIENCES LTD. (KR) | 2013-07-09 | — | — | US | disclosed |
| US-20090291959-A1 | CASPASE INHIBITORS BASED OF PYRIDAZINONE SCAFFOLD | LG LIFE SCIENCES LTD. (KR) | 2009-11-26 | — | — | US | disclosed |
| CN-101506174-A | Caspase inhibitors based on pyridazinone scaffold | LG LIFE SCIENCES LTD (KR) | 2009-08-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090291959-A1 | CASPASE INHIBITORS BASED OF PYRIDAZINONE SCAFFOLD | CASP1, CASP2, CASP5 | ALDH1A1 3705/4885RAB9A 3925/4885HTT 3351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.